The international cooperative ataxia rating scale shows strong age-dependency in children

Developmental Medicine and Child Neurology

Volumn 51, Issue 7, 2009, Pages 571-572

  Sival, Deborah A ^a   Brunt, Ewout R ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; BODY POSTURE; CEREBELLAR ATAXIA; CHILD; CLINICAL EVALUATION; COORDINATION; EYE MOVEMENT; FUNCTIONAL ASSESSMENT; GAIT; HUMAN; INTERNATIONAL COOPERATIVE ATAXIA RATING SCALE; LETTER; LIMB; MOTOR PERFORMANCE; PRIORITY JOURNAL; RATING SCALE; REFERENCE VALUE; SCORING SYSTEM; SPEECH; TASK PERFORMANCE;

ADOLESCENT; AGE FACTORS; ATAXIA; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DISABLED CHILDREN; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INTERNATIONAL COOPERATION; MALE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 67049119061     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2009.03334.x     Document Type: Letter

References (13)

1. Lodi R, Rajagopalan B, Blamire AM, et.al. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: An in vivo 31P magnetic resonance spectroscopy study. Cardiovasc Res 2001; 52: 111-19.
2. Mori M, Adachi Y, Mori N, et al. Double-blind crossover study of branched-chain amino acid therapy in patients with spinocerebellar degeneration. J Neurol Sci 2002; 195: 149-52.
3. Hassin-Baer S, Korczyn AD, Giladi N. An open trial of amantadine and buspirone for cerebellar ataxia: A disappointment. J Neural Transm 2000; 107: 1187-89.
4. Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997; 145: 205-11.
5. Di Prospero NA, Baker A, Jeffries N, Fischbeck KH. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: A randomised, placebo-controlled trial. Lancet Neurol 2007; 6: 878-86.
6. Artuch R, Aracil A, Mas A, et al. Friedreich's ataxia: Idebenone treatment in early stage patients. Neuropediatrics 2002; 33: 190-93.
7. Pineda M, Arpa J, Montero R, et al. Idebenone treatment in paediatric and adult patients with Friedreich ataxia: Long-term follow-up. Eur J Paediatr Neurol 2008; 12: 470-75.
8. Gabsi S, Gouider-Khouja N, Belal S, et al. Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency. Eur J Neurol 2001; 8: 477-81.
9. Ilg W, Giese MA, Gizewski ER, Schoch B, Timmann D. The influence of focal cerebellar lesions on the control and adaptation of gait. Brain 2008; 131: 2913-27.
10. Schoch B, Regel JP, Frings M, et al. Reliability and validity of ICARS in focal cerebellar lesions. Mov Disord 2007; 22: 2162-9.
11. Wang PS, Liu RS, Yang BH, Soong BW. Topographic brain mapping of the international cooperative ataxia rating scale. A positron emission tomography study. J Neurol 2007; 254: 722-28.
12. Largo RH, Caflisch JA, Hug F, et al. Neuromotor development from 5 to 18 years. Part 1: Timed performance. Dev Med Child Neurol 2001; 43: 436-43.
13. Largo RH, Caflisch JA, Hug F, et al. Neuromotor development from 5 to 18 years. Part 2: Associated movements. Dev Med Child Neurol 2001; 43: 444-53.